Lisa Ricciardi, president and CEO of Cognition Therapeutics was recently a guest on Benzinga's All-Access. Cognition ...

As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...

It's crucial to consult your GP before introducing any new over-the-counter medication into your routine. While there are promising studies suggesting vitamin D could combat dementia, it's ...

The findings show that the increased ... Study Identifies Potential New Drug for Parkinson's-Related Cognitive Decline, Dementia Nov. 19, 2024 — A recently published study found that a tiny ...

Always speak to your doctor first before adding any new over-the-counter medication to your diet. It is also important to note that while various studies on the power vitamin D may have against ...

Effectively treating and preventing this common form of dementia will require a cocktail of drugs and a combination of ...

Always speak to your doctor first before adding any new over-the-counter medication to your diet ... on the power vitamin D may have against dementia show promising results, further clinical ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

Alpha Cognition and China Medical System sign a $44M licensing deal for Zunveyl. ALPHA-1062 preclinical data shows benefits ...

For decades, scientists have been trying to develop therapeutics for people living with Alzheimer’s disease, a progressive ...

How Dementia Affects the ... of Huntington's disease (HD), according to a new ... 'Alzheimer's in Dish' Model Shows Promise for Accelerating Drug Discovery Nov. 27, 2024 — A decade ago ...